相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
NOX2-derived reactive oxygen species in immune cells exacerbates salt-sensitive hypertension
Justine M. Abais-Battad et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Oxidative stress – A unifying paradigm in hypertension
Rhian M. Touyz et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Molecular genetics of human hypertension
Friedrich C. Luft
CURRENT OPINION IN CARDIOLOGY (2020)
The global epidemiology of hypertension
Katherine T. Mills et al.
NATURE REVIEWS NEPHROLOGY (2020)
A Community-Based Intervention for Managing Hypertension in Rural South Asia
Tazeen H. Jafar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Bohm et al.
LANCET (2020)
Device-based therapies for arterial hypertension
Lucas Lauder et al.
NATURE REVIEWS CARDIOLOGY (2020)
Device-Based Neuromodulation for Resistant Hypertension Therapy Too Early for Prime Time?
Thomas E. Lohmeier et al.
CIRCULATION RESEARCH (2019)
Prevalence of Apparent Treatment-Resistant Hypertension in the United States: Comparison of the 2008 and 2018 American Heart Association Scientific Statements on Resistant Hypertension
Robert M. Carey et al.
HYPERTENSION (2019)
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
George L. Bakris et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Luis M. Ruilope et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari et al.
LANCET (2018)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi et al.
LANCET (2018)
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels A Systematic Review and Meta-analysis
Mattias Brunstrom et al.
JAMA INTERNAL MEDICINE (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Pharmacokinetics, distribution, and disposition of esaxerenone, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist, in rats and monkeys
Makiko Yamada et al.
XENOBIOTICA (2017)
Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy Results of the 6-Year Open Follow-Up
Peter W. de Leeuw et al.
HYPERTENSION (2017)
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension A Randomized and Prospective Study (CANZONE Study)
Yuhei Shiga et al.
INTERNATIONAL HEART JOURNAL (2017)
Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide
Joel M. Neutel et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
Mineralocorticoid receptor antagonists: 60 years of research and development
Peter Kolkhof et al.
JOURNAL OF ENDOCRINOLOGY (2017)
An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems
Rolf Wachter et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2017)
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study
Wilko Spiering et al.
LANCET (2017)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend et al.
LANCET (2017)
Renin-angiotensin system blockade: Finerenone
Luis M. Ruilope et al.
NEPHROLOGIE & THERAPEUTIQUE (2017)
Blood Pressure and the Renal Actions of AT2 Receptors
Robert M. Carey
CURRENT HYPERTENSION REPORTS (2017)
Multidisciplinary Approach in the Treatment of Resistant Hypertension
S. A. Potthoff et al.
CURRENT HYPERTENSION REPORTS (2017)
First reported cases: renal denervation with second-generation multi-electrode catheter via brachial and radial access
M. J. Heradien et al.
CARDIOVASCULAR JOURNAL OF AFRICA (2016)
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Scott A. Hubers et al.
CIRCULATION (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Externally Delivered Focused Ultrasound for Renal Denervation
Petr Neuzil et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats
Kiyoshi Arai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The CUL3/KLHL3-WNK-SPAK/OSR1 pathway as a target for antihypertensive therapy
Mohammed Z. Ferdaus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
E. Bruce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
New Approaches in the Treatment of Hypertension
Suzanne Oparil et al.
CIRCULATION RESEARCH (2015)
The Epidemiology of Blood Pressure and Its Worldwide Management
Kazem Rahimi et al.
CIRCULATION RESEARCH (2015)
The Sympathetic Nervous System Alterations in Human Hypertension
Guido Grassi et al.
CIRCULATION RESEARCH (2015)
Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN™ I first-in-human study using a multi-electrode ablation system
Costas P. Tsioufis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses
Costas Thomopoulos et al.
JOURNAL OF HYPERTENSION (2015)
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial
Melvin D. Lobo et al.
LANCET (2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams et al.
LANCET (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension Six-Month Results From the Prague-15 Study
Jan Rosa et al.
HYPERTENSION (2015)
Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO)
W. Frank Peacock et al.
AMERICAN HEART JOURNAL (2014)
Percutaneous Computer Tomography-Guided Ethanol Sympathicolysis for the Treatment of Resistant Arterial Hypertension
F. Streitparth et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
Chemical Renal Denervation by Vincristine: The Role of the Flow Rate of Delivery
Christodoulos Stefanadis et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Clevidipine: A Review of Its Use for Managing Blood Pressure in Perioperative and Intensive Care Settings
Gillian M. Keating
DRUGS (2014)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial
Murray D. Esler et al.
EUROPEAN HEART JOURNAL (2014)
CRISPR/Cas9 for genome editing: progress, implications and challenges
Feng Zhang et al.
HUMAN MOLECULAR GENETICS (2014)
Arteriovenous Anastomosis Is This the Way to Control Hypertension?
Amy E. Burchell et al.
HYPERTENSION (2014)
Refractory Hypertension Determination of Prevalence, Risk Factors, and Comorbidities in a Large, Population-Based Cohort
David A. Calhoun et al.
HYPERTENSION (2014)
Improvement of albuminuria after renal denervation
Christian Ott et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials
T. Dorniak-Wall et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Blood pressure changes after renal denervation at 10 European expert centers
A. Persu et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
Henry Krum et al.
LANCET (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hypertension Vaccine may be a boon to millions in developing world
Mohan Bairwa et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The role of nutrition and nutraceutical supplements in the treatment of hypertension
Mark Houston
WORLD JOURNAL OF CARDIOLOGY (2014)
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2013)
Noninvasive Renal Sympathetic Denervation by Extracorporeal High-Intensity Focused Ultrasound in a Pre-Clinical Canine Model
Qifeng Wang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model
Tim A. Fischell et al.
EuroIntervention (2013)
Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease
Colin Cunnington et al.
CIRCULATION (2012)
The Role of Matrix Metalloproteinases in Essential Hypertension
Emmanuel Androulakis et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Renal Denervation Ultima Ratio or Standard in Treatment-Resistant Hypertension
Alexandre Persu et al.
HYPERTENSION (2012)
Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension
Mathias C. Brandt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Central Hemodynamics in Patients With Resistant Hypertension
Mathias C. Brandt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial
Uta C. Hoppe et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial
George L. Bakris et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S. Lim et al.
LANCET (2012)
SPAK and WNK kinases: a new target for blood pressure treatment?
Mark Glover et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Inflammation in Hypertension: Current Therapeutic Approaches
Emmanuel Androulakis et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Prevalence of Resistant Hypertension in the United States, 2003-2008
Stephen D. Persell
HYPERTENSION (2011)
The Comparative Effects of Azilsartan Medoxomil and Olmesartan on Ambulatory and Clinic Blood Pressure
George L. Bakris et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension Results From European and United States Trials of the Rheos System
John D. Bisognano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial
John D. Bisognano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Implantation of a Carotid Baroreceptor Stimulator in Patients with Pacemakers and Hypertension
Harischandra Karunaratne et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2011)
Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients - An open, pilot study
Agnieszka M. Kuklinska et al.
BLOOD PRESSURE (2010)
Clevidipine for the Treatment of Severe Hypertension in Adults
Huan M. Nguyen et al.
CLINICAL THERAPEUTICS (2010)
Inflammatory Markers in Essential Hypertension: Potential Clinical Implications
Elli Stefanadi et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Carotid Baroreceptor Stimulation, Sympathetic Activity, Baroreflex Function, and Blood Pressure in Hypertensive Patients
Karsten Heusser et al.
HYPERTENSION (2010)
Novel Baroreflex Activation Therapy in Resistant Hypertension Results of a European Multi-Center Feasibility Study
Ingrid J. M. Scheffers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Essential Hypertension Is There a Role for Inflammatory Mechanisms?
Emmanuel S. Androulakis et al.
CARDIOLOGY IN REVIEW (2009)
RNA interference targeting the ACE gene reduced blood pressure and improved myocardial remodelling in SHRs
Junhua He et al.
CLINICAL SCIENCE (2009)
DISEASE PREVENTION The moving target of global cardiovascular health
Rajesh Vedanthan et al.
NATURE REVIEWS CARDIOLOGY (2009)
Drug Therapy Use of Diuretics in Patients with Hypertension
Michael E. Ernst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vascular protection by tetra hydrobiopterin: progress and therapeutic prospects
Zvonimir S. Katusic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients
Solomon Aronson et al.
ANESTHESIA AND ANALGESIA (2008)
Angiotensin II Type 2 Receptor Stimulation A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
Elena Kaschina et al.
CIRCULATION (2008)
Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial
Neil Chapman et al.
CIRCULATION (2008)
Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia
Chang-Jiang Ge et al.
HEART AND VESSELS (2008)
Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure:: a double-blind, randomised, placebo-controlled phase IIa study
Alain C. Tissot et al.
LANCET (2008)
Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction
Tomasz J. Guzik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Statins: another class of antihypertensive agents?
HJ Milionis et al.
JOURNAL OF HUMAN HYPERTENSION (2006)
Mechanisms, pathophysiology, and therapy of arterial stiffness
SJ Zieman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects
MJ Brown et al.
CLINICAL SCIENCE (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States
K Wolf-Maier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries
D Tousoulis et al.
HEART (2003)
Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats
HJ Hong et al.
HYPERTENSION (2001)
L-Arginine improves endothelial function in renal artery of hypertensive Dahl rats
MS Zhou et al.
JOURNAL OF HYPERTENSION (2001)
分享论文
